Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Fertility preserving options for women of advancing age

Karine Chung, MD, MSCE
Richard Paulson, MD
Section Editor
Robert L Barbieri, MD
Deputy Editor
Kristen Eckler, MD, FACOG


Population-based birth statistics demonstrate a consistent increase in the proportion of women choosing to delay childbearing until later in their reproductive years [1]. This trend has largely been attributed to the increase in women pursuing postgraduate educational degrees and higher levels of professional achievement, activities whose demands for time and energy compete with those of starting a family [2].

Because the ability to conceive is strongly influenced by a woman's age, many women who delay childbearing may face infertility by the time they are ready to become pregnant. The prevalence of infertility increases significantly after age 35 year, and by age 45 years, as many as 99 percent of women are infertile [3]. (See "Effects of advanced maternal age on pregnancy".)

As the trend to delay childbearing continues, and as awareness of the age-related decline in fertility increases, interest in the emerging technologies of fertility preservation has grown. Although these procedures are commonly considered for women undergoing sterilizing treatments (eg, chemotherapy, radiation therapy, ovarian resection), elective use of fertility preservation techniques among women of advancing reproductive age remains controversial [4-8].

Fertility preservation options that may be applied to women of advancing reproductive age will be discussed here. Preservation of fertility in patients undergoing sterilizing therapies is reviewed separately. (See "Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection".)


The influence of female age on fertility has been clearly established by a number of observational studies, which have consistently demonstrated a decline in pregnancy rates with advancing maternal age. Furthermore, cycles that result in pregnancy are less likely to progress to live births because of higher rates of miscarriage among older women. These relationships are best illustrated by outcome data from clinics performing in vitro fertilization (table 1). (See "Effects of advanced maternal age on pregnancy".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 06, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. National Center for Health Statistics. Birth rate for women age 15-44. www.cdc.gov/nchs/pressroom/04facts/birthrates.htm (Accessed on October 29, 2008).
  2. Mathews, TJ, Ventura, SJ. National Vital Statistics Report. Birth and Fertility Rates by Educational Attainment: United States, 1994. www.cdc.gov/nchs/pressroom/97facts/edu2birt.htm. (Accessed on November 07, 2008).
  3. Menken J, Trussell J, Larsen U. Age and infertility. Science 1986; 233:1389.
  4. ESHRE Task Force on Ethics and Law, Dondorp W, de Wert G, et al. Oocyte cryopreservation for age-related fertility loss. Hum Reprod 2012; 27:1231.
  5. Hirshfeld-Cytron J, Grobman WA, Milad MP. Fertility preservation for social indications: a cost-based decision analysis. Fertil Steril 2012; 97:665.
  6. Lockwood GM. Social egg freezing: the prospect of reproductive 'immortality' or a dangerous delusion? Reprod Biomed Online 2011; 23:334.
  7. Mertes H, Pennings G. Elective oocyte cryopreservation: who should pay? Hum Reprod 2012; 27:9.
  8. Mertes H, Pennings G. Social egg freezing: for better, not for worse. Reprod Biomed Online 2011; 23:824.
  9. Rao GD, Chian RC, Son WS, et al. Fertility preservation in women undergoing cancer treatment. Lancet 2004; 363:1829.
  10. Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7:1342.
  11. Volarcik K, Sheean L, Goldfarb J, et al. The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum Reprod 1998; 13:154.
  12. Pellestor F, Andréo B, Arnal F, et al. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet 2003; 112:195.
  13. Stolwijk AM, Zielhuis GA, Sauer MV, et al. The impact of the woman's age on the success of standard and donor in vitro fertilization. Fertil Steril 1997; 67:702.
  14. Sauer MV, Paulson RJ, Lobo RA. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 1992; 268:1275.
  15. Paulson RJ, Hatch IE, Lobo RA, Sauer MV. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12:835.
  16. Pickering SJ, Braude PR, Johnson MH. Cryoprotection of human oocytes: inappropriate exposure to DMSO reduces fertilization rates. Hum Reprod 1991; 6:142.
  17. Centers for Disease Control and Prevention. 2014 Assisted Reproductive Technology Fertility Clinic Success Rates Report. September 2016. www.cdc.gov/art/reports/2014/fertility-clinic.html (Accessed on October 06, 2017).
  18. Wilson C, Check JH, Summers-Chase D, Swenson K. Successful pregnancies from embryos cryopreserved more than ten years: two case reports. Clin Exp Obstet Gynecol 2006; 33:79.
  19. Aytoz A, Van den Abbeel E, Bonduelle M, et al. Obstetric outcome of pregnancies after the transfer of cryopreserved and fresh embryos obtained by conventional in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod 1999; 14:2619.
  20. Shih W, Rushford DD, Bourne H, et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod 2008; 23:1644.
  21. Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013; 99:37.
  22. ACOG: Committee Opinion No. 584: oocyte cryopreservation. Obstet Gynecol 2014; 123:221.
  23. Ho JR, Woo I, Louie K, et al. A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos. J Assist Reprod Genet 2017; 34:1359.
  24. Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the American Society for Reproductive Medicine. Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion. Fertil Steril 2007; 88:1495.
  25. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986; 1:884.
  26. Jain JK, Paulson RJ. Oocyte cryopreservation. Fertil Steril 2006; 86:1037.
  27. Gardner DK, Sheehan CB, Rienzi L, et al. Analysis of oocyte physiology to improve cryopreservation procedures. Theriogenology 2007; 67:64.
  28. Ghetler Y, Skutelsky E, Ben Nun I, et al. Human oocyte cryopreservation and the fate of cortical granules. Fertil Steril 2006; 86:210.
  29. Wortzman GB, Evans JP. Membrane and cortical abnormalities in post-ovulatory aged eggs: analysis of fertilizability and establishment of the membrane block to polyspermy. Mol Hum Reprod 2005; 11:1.
  30. Schalkoff ME, Oskowitz SP, Powers RD. Ultrastructural observations of human and mouse oocytes treated with cryopreservatives. Biol Reprod 1989; 40:379.
  31. Kazem R, Thompson LA, Srikantharajah A, et al. Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod 1995; 10:2650.
  32. Porcu E, Fabbri R, Seracchioli R, et al. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril 1997; 68:724.
  33. Mazur P. Limits to life at low temperatures and at reduced water contents and water activities. Orig Life 1980; 10:137.
  34. Fabbri R, Porcu E, Marsella T, et al. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod 2001; 16:411.
  35. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86:70.
  36. Kuleshova L, Gianaroli L, Magli C, et al. Birth following vitrification of a small number of human oocytes: case report. Hum Reprod 1999; 14:3077.
  37. Kuwayama M, Vajta G, Ieda S, Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online 2005; 11:608.
  38. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011; 96:277.
  39. Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 2013; 99:1503.
  40. Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod 2017; 32:1046.
  41. Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 2014; 101:1237.
  42. Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril 2015; 103:1551.
  43. Goldman RH, Racowsky C, Farland LV, et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod 2017; 32:853.
  44. Cobo A, García-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016; 105:755.
  45. Bianchi V, Lappi M, Bonu MA, Borini A. Oocyte slow freezing using a 0.2-0.3 M sucrose concentration protocol: is it really the time to trash the cryopreservation machine? Fertil Steril 2012; 97:1101.
  46. Ubaldi F, Anniballo R, Romano S, et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod 2010; 25:1199.
  47. Spandorfer SD, Bendikson K, Dragisic K, et al. Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes. Fertil Steril 2007; 87:74.
  48. Quintans CJ, Donaldson MJ, Bertolino MV, Pasqualini RS. Birth of two babies using oocytes that were cryopreserved in a choline-based freezing medium. Hum Reprod 2002; 17:3149.
  49. Boldt J, Tidswell N, Sayers A, et al. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method. Reprod Biomed Online 2006; 13:96.
  50. Levi Setti PE, Albani E, Novara PV, et al. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006; 21:370.
  51. Cobo A, Serra V, Garrido N, et al. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril 2014; 102:1006.
  52. Sathananthan AH, Trounson A, Freemann L, Brady T. The effects of cooling human oocytes. Hum Reprod 1988; 3:968.
  53. Pickering SJ, Braude PR, Johnson MH, et al. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 1990; 54:102.
  54. Rienzi L, Martinez F, Ubaldi F, et al. Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 2004; 19:655.
  55. Cobo A, Pérez S, De los Santos MJ, et al. Effect of different cryopreservation protocols on the metaphase II spindle in human oocytes. Reprod Biomed Online 2008; 17:350.
  56. Gook DA, Osborn SM, Bourne H, Johnston WI. Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Hum Reprod 1994; 9:684.
  57. Cobo A, Rubio C, Gerli S, et al. Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes. Fertil Steril 2001; 75:354.
  58. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009; 18:769.
  59. Winslow KL, Yang D, Blohm PL, et al. Oocyte cryopreservation: a three year follow-up of sixteen births. Fertil Steril 2001; 76:S120.
  60. Porcu E, Fabbri R, Damiano G, et al. Clinical experience and applications of oocyte cryopreservation. Mol Cell Endocrinol 2000; 169:33.
  61. Chian RC, Huang JY, Tan SL, et al. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online 2008; 16:608.